|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.7 TWD | -0.72% |
|
-1.15% | -8.16% |
| 05-10 | Bionime Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-15 | Bionime Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Bionime Corporation reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 468.47 million compared to TWD 415.12 million a year ago. Net loss was TWD 5.04 million compared to TWD 5.65 million a year ago.
Basic loss per share from continuing operations was TWD 0.08 compared to TWD 0.09 a year ago. Diluted loss per share from continuing operations was TWD 0.08 compared to TWD 0.09 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.16% | 130M | |
| -6.06% | 12.09B | |
| -3.26% | 8.21B | |
| +5.00% | 5.74B | |
| +31.20% | 5.64B | |
| -9.05% | 4.16B | |
| -56.99% | 2.88B | |
| +11.87% | 2.69B | |
| -7.50% | 2.33B | |
| +25.34% | 2.17B |
BIONIME CORPORATION 
